We are live on ! Find out more
PM

Parametrica Management Portfolio holdings

AUM $88M
1-Year Est. Return 48.84%
This Fund
S&P 500
This Quarter Est. Return
+13%
1 Year Est. Return
+48.84%
3 Year Est. Return
+257.17%
5 Year Est. Return
+315.15%
10 Year Est. Return
–
AUM
$135M
AUM Growth
-$72.6M
Cap. Flow
-$83.8M
Cap. Flow %
-61.9%
Top 10 Hldgs %
44.33%
Holding
205
New
45
Increased
16
Reduced
31
Closed
110

Top Buys

Rank Stock Value
1
BNTX icon
BioNTech
BNTX
+$3.07M
2
STNE icon
StoneCo
STNE
+$2.15M
3
TLRY icon
Tilray
TLRY
+$2.07M
4
CRM icon
Salesforce
CRM
+$2.02M
5
IOVA icon
Iovance Biotherapeutics
IOVA
+$1.93M

Top Sells

Rank Stock Value
1
JD icon
JD.com
JD
+$8.2M
2
NCLH icon
Norwegian Cruise Line
NCLH
+$7.85M
3
TME icon
Tencent Music
TME
+$7.63M
4
NXST icon
Nexstar Media Group
NXST
+$5.3M
5
CVAC
CureVac
CVAC
+$3.97M

Sector Composition

Rank Sector Weight
1 Communication Services 28.24%
2 Consumer Discretionary 21.22%
3 Healthcare 18.41%
4 Technology 17.13%
5 Industrials 5.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UBER icon
26
Uber
UBER
$145B
$1.87M 1.38%
37,283
-31,779
-46% -$1.66M
AMAT icon
27
Applied Materials
AMAT
$347B
$1.84M 1.36%
12,901
-3,349
-21% -$449K
PARA
28
DELISTED
Paramount Global Class B
PARA
$1.77M 1.31%
39,220
+488
+1% +$20.2K
DAL icon
29
Delta Air Lines
DAL
$56.7B
$1.63M 1.21%
37,722
+5,695
+18% +$264K
SNAP icon
30
Snap
SNAP
$7.96B
$1.58M 1.17%
23,193
-3,636
-14% -$218K
MSFT icon
31
Microsoft
MSFT
$2.9T
$1.43M 1.05%
5,258
-517
-9% -$131K
BLUE
32
DELISTED
bluebird bio
BLUE
$1.39M 1.02%
3,351
+440
+15% +$174K
DHI icon
33
D.R. Horton
DHI
$41.2B
$1.37M 1.01%
15,160
+2,970
+24% +$279K
QFIN icon
34
Qfin Holdings
QFIN
$1.68B
$1.31M 0.97%
+31,370
New +$956K
CDAK
35
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$1.29M 0.95%
+69,584
New +$1.34M
PHM icon
36
Pultegroup
PHM
$25.2B
$1.24M 0.92%
22,749
+3,200
+16% +$179K
RCL icon
37
Royal Caribbean
RCL
$86.5B
$1.2M 0.89%
+14,078
New +$1.23M
LIN icon
38
Linde
LIN
$236B
$1.16M 0.86%
4,026
-4,529
-53% -$1.32M
JD icon
39
JD.com
JD
$43.5B
$1.14M 0.84%
14,280
-108,900
-88% -$8.2M
NXST icon
40
Nexstar Media Group
NXST
$6.01B
$1.09M 0.8%
7,354
-35,617
-83% -$5.3M
GBT
41
DELISTED
Global Blood Therapeutics, Inc.
GBT
$850K 0.63%
24,275
+253
+1% +$9.88K
GTN icon
42
Gray Television
GTN
$437M
$832K 0.61%
35,602
– –
ACAD icon
43
Acadia Pharmaceuticals
ACAD
$4.51B
$744K 0.55%
30,516
+6,174
+25% +$139K
WOLF icon
44
Wolfspeed
WOLF
$1.04B
$731K 0.54%
+7,469
New +$753K
TME icon
45
Tencent Music
TME
$15.9B
$714K 0.53%
46,152
-461,157
-91% -$7.63M
BABA icon
46
Alibaba
BABA
$276B
$639K 0.47%
2,816
-9,900
-78% -$2.2M
BA icon
47
Boeing
BA
$169B
$494K 0.36%
+2,063
New +$499K
WBD icon
48
Warner Bros
WBD
$64.3B
$462K 0.34%
+15,054
New +$522K
SHOP icon
49
Shopify
SHOP
$168B
$438K 0.32%
3,000
-18,050
-86% -$2.22M
ZTS icon
50
Zoetis
ZTS
$32.7B
$417K 0.31%
2,237
-124
-5% -$21.5K
1
2
3 4 5

Similar funds

BCP
Balance Capital Partners New York $87.9M AUM
PBCM
Point Break Capital Management Miami, Florida $88M AUM
CVM
Civilization Ventures Management Belvedere Tiburon, California $87.9M AUM
XXIP
Xiamen Xinweidachuang Investment Partnership Xiamen, China $87.8M AUM 29.25% 1-Year Est. Return
DG
Daventry Group New York $87.8M AUM 3.83% 1-Year Est. Return
RFL
RD Finance Ltd Limassol, Cyprus $88.1M AUM 11.44% 1-Year Est. Return
IAP
Indie Asset Partners Carmel, Indiana $87.8M AUM 27.76% 1-Year Est. Return
MPEM
Marathon Partners Equity Management New York $88.3M AUM 20.65% 1-Year Est. Return

Parametrica Management's Q2 2021 Portfolio in Review

As of Q2 2021, Parametrica Management held 205 positions worth $135M, down 35% from $208M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Parametrica Management withdrew a net $83.8M in Q2 2021, closing 110 positions and reducing 31 holdings. Its most notable exit was CureVac, an estimated $3.97M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 28% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Parametrica Management opened a new position in Tilray worth $2.13M.

  • Parametrica Management's largest Q2 2021 buy was Tilray: 11,809 shares worth $2.13M.
  • Parametrica Management added most to BioNTech in Q2 2021, an estimated $3.07M increase.
  • Parametrica Management's biggest Q2 2021 reduction was JD.com, cutting an estimated $8.2M.
  • Parametrica Management fully exited CureVac in Q2 2021, selling an estimated $3.97M.
  • Parametrica Management's ten largest holdings make up 44% of its $135M portfolio in Q2 2021.
  • Parametrica Management opened 45 new positions and closed 110 in Q2 2021.
  • Parametrica Management's portfolio value fell 35% quarter-over-quarter to $135M.

Based on Parametrica Management's 13F filing for Q2 2021, filed 13 Aug 2021.